Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning
Frontiers in Cellular and Infection Microbiology · 13.03.2024 · 14
DOI: 10.3389/fcimb.2024.1384244 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 13.03.2024. Verfasst von Taís Fontoura de Almeida und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiopathology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal Universit…. Hauptthemen laut MEDLINE: Biological Products, Leishmaniasis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning Leishmaniasis is a group of tropical diseases that affect millions of people worldwide.These diseases are transmitted by vectors and caused by protozoa of the genus Leishmania.The WHO reported that in 2020, Leishmaniasis was present in 98 countries or territories, and it posed a severe public health issue in four eco-epidemiological regions: Americas, East Africa, North Africa, West and Southeast Asia.That year, there were reports of 208,357 cases of Cutaneous Leishmaniasis (CL) and 12,838 cases of Visceral Leishmaniasis (VL) (Ruiz-Postigo et al., 2021).For the last 70 years, the available chemotherapy has been constituted by first-line (pentavalent antimonials) and second-line drugs (amphotericin B, pentamidine, paramomycin, and miltefosine).Existing drugs generally have disadvantages related to therapeutic approaches, such as route of administration, the need for trained professionals for administration, toxicity, high cost.Considering the number of pathogenic species concerning therapeutic options, this arsenal still needs to be improved (Burza et al., 2018).The lack of a vaccine or effective chemotherapy has stimulated many studies Frontiers in Cellular and Infection Microbiology frontiersin.org01
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Physiopathology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil.
- Laboratory of Immunoparasitology, Institute of Pharmaceutical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil.
- Laboratory of Immunoparasitology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil.
- Drug Discovery Unit, Department of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
- Institute of Veterinary, Department of Veterinary Microbiology and Immunology, Seropédica, RJ, Brazil.
- St Michael Hospital, Li ka Shing Knowledge Institute, Toronto, ON, Canada.
Zitieren
APA
de Almeida, T. F., Cunha-Junior, E. F., Wanderley, J. L. M., Pacheco, J. D. S., Pinto-da-Silva, L. H., Andrade-Neto, V. V., & Chaves, S. P. (2024). Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1384244
Vancouver
de Almeida TF, Cunha-Junior EF, Wanderley JLM, Pacheco JDS, Pinto-da-Silva LH, Andrade-Neto VV, et al. Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1384244
BibTeX
@article{deAlmeida2024,
author = {de Almeida, Taís Fontoura and Cunha-Junior, Edézio Ferreira and Wanderley, João Luiz Mendes and Pacheco, Juliana da Silva and Pinto-da-Silva, Lucia Helena and Andrade-Neto, Valter Viana and Chaves, Suzana Passos},
title = {Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1384244}
}
EUVIMED